3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Leukemia, Promyelocytic, Acute
1
Disease
1
Colorectal Neoplasms
1
Colitis
1
Breast Neoplasms
1
Interventions
Cytarabine
16
Arsenic Trioxide
11
Tretinoin
10
Methotrexate
10
Cyclophosphamide
9
Idarubicin
8
Filgrastim
7
Mercaptopurine
6
Busulfan
6
fludarabine phosphate
5
Etoposide
5
Vorinostat
4
Topotecan
4
Sorafenib
4
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Daunorubicin
4
Clofarabine
4
Granulocyte Colony-Stimulating Factor
3
Gemtuzumab
3
Azacitidine
3
Antilymphocyte Serum
3
romidepsin
2
merphos
2
lintuzumab
2
entinostat
2
Thiotepa
2
Tacrolimus
2
Mitoxantrone
2
Lenalidomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leukemia, Promyelocytic, Acute
×
Diagnosis
×
Clear all
NCT04562818
2020-09-24
Mexico APL
Instituto Nacional de Cancerologia de Mexico
Completed
360 enrolled